No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
IQV IQVIA Holdings
- 211.655
- -2.305-1.08%
Trading Jun 14 12:29 ET
38.56BMarket Cap28.91P/E (TTM)
213.380High210.790Low283.10KVolume213.050Open213.960Pre Close59.89MTurnover0.16%Turnover Ratio29.03P/E (Static)182.20MShares261.73052wk High6.08P/B38.20BFloat Cap167.42052wk Low--Dividend TTM180.50MShs Float285.610Historical High--Div YieldTTM1.21%Amplitude81.790Historical Low211.548Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | IQVIA Holdings Inc : Baird Cuts Target Price to $241 From $245
Express News | IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?
A Closer Look At IQVIA Holdings Inc.'s (NYSE:IQV) Impressive ROE
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. We'll use ROE to e
Should You Be Impressed By IQVIA Holdings Inc.'s (NYSE:IQV) ROE?
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said AbbVie Inc. (NYSE:ABBV) is a very solid pharmaceutical company. The company has good dividend yield and attractive valua
Comments
From YouTube
6
Insiders' substantial share sale, especially by W. Staub and Constantinos Panagos, may worry shareholders. The lack of insider purchases over the past year could be a negative sign. Yet, high insider ownership might indicate well-aligned management incentives with shareholders.
$IQVIA Holdings(IQV.US$ Aced the numbers again in a very competitive market
The market's opinion of the business has improved over the past five years, likely due to consistent earnings growth. Despite recent sell-offs, if fundamentals suggest sustainable long-term growth, this could be a worthwhile opportunity.
IQVIA Holdings is currently undervalued and has a bright future. Its growth hasn't been fully factored into the share price. It may be a great time to increase holdings or enter the stock.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
